BCL2L1 and cancer: This STAT3 ODN-decoy has been tested in various cancer cell lines, where it displayed promising effects, such as apoptosis induction, diminution of cancer cell proliferation, and reduction in Bcl-xL and cyclin D1 gene expression (Zhang et al., 2007).